News and Media
Press Releases
Bloom Science Reports Positive Data from Phase 1 Trial of BL-001 Demonstrating Statistically Significant, Durable Weight Loss in Overweight Individuals
Bloom Science Reports Positive Data from Phase 1 Trial of BL-001 Demonstrating Statistically Significant, Durable Weight Loss in Overweight Individuals BL-001 achieved statistically significant...
Bloom Science to Present at the Sachs 8th Annual Neuroscience Innovation Forum
Bloom Science to Present at the Sachs 8th Annual Neuroscience Innovation Forum SAN DIEGO, Calif., January 10, 2025 - Bloom Science, Inc., a clinical-stage biotech company focused on the development...
Bloom Science to Present at the Sachs 1st Annual Biopharma Obesity Innovation Forum
Bloom Science to Present at the Sachs 1st Annual Biopharma Obesity Innovation Forum SAN DIEGO, Calif., January 9, 2025 - Bloom Science, Inc., a clinical-stage biotech company focused on the...
Bloom Science Announces Poster Presentations at the 2024 American Epilepsy Society Annual Meeting
Bloom Science Announces Poster Presentations at the 2024 American Epilepsy Society Annual Meeting SAN DIEGO, Calif., December 5, 2024 - Bloom Science, Inc., a clinical-stage biotech company...
Bloom Science to Present at Connecting Microbiome Communities Conference
Bloom Science to Present at Connecting Microbiome Communities Conference SAN DIEGO, Calif., November 1, 2024 - Bloom Science, Inc., a clinical-stage biotech company focused on the development...
Bloom Science to Present at 24th Annual Biotech in Europe Forum
Bloom Science to Present at 24th Annual Biotech in Europe Forum SAN DIEGO, Calif., September 24, 2024 - Bloom Science, Inc., a clinical-stage biotech company focused on the development of...
Christopher Reyes, Founder and CEO of Bloom Science, joins a panel of experts to explore the Science of the Gut-Brain Axis
Christopher Reyes, Founder and CEO of Bloom Science, joins a panel of experts to explore the Science of the Gut-Brain Axis SAN DIEGO, Calif., August 5, 2024 —Bloom Science, Inc., a clinical-stage...
Bloom Science to Participate at Upcoming Patient Advocacy Conferences
Bloom Science to Participate at Upcoming Patient Advocacy Conferences SAN DIEGO, Calif., June 20, 2024 — Bloom Science, Inc., a clinical-stage biotech company focused on the development of...
Bloom CEO Christopher Reyes, PhD Patriciates on IamBIO podcast Focused on Exploring the Science of the Microbiome
Bloom CEO Christopher Reyes, PhD Patriciates on IamBIO podcast Focused on Exploring the Science of the Microbiome SAN DIEGO, Calif., March 12, 2024 —The gut microbiome plays a crucial role in our...
Bloom Science to Present at the Biocom Global Partnering & Investor Conference
Bloom Science to Present at the Biocom Global Partnering & Investor Conference SAN DIEGO, Calif., February 20, 2024 — Bloom Science, Inc., today announced that Christopher Reyes, Ph.D.,...
Bloom Science Granted Multiple New US and EU Patents Strengthening its IP Portfolio
Bloom Science Granted Multiple New US and EU Patents Strengthening its IP Portfolio SAN DIEGO, Calif., January 31, 2024 —Bloom Science, Inc., today announced that the United States Patent and...
Bloom Science to Present at the 7th Annual Sachs Neuroscience Innovation Forum
Bloom Science to Present at the 7th Annual Sachs Neuroscience Innovation Forum SAN DIEGO, Calif., January 2, 2024 - Bloom Science, Inc., today announced that Christopher Reyes, Ph.D., Chief...